000 01133 a2200313 4500
005 20250512033319.0
264 0 _c19890510
008 198905s 0 0 eng d
022 _a0950-3552
024 7 _a10.1016/s0950-3552(88)80046-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCameron, I T
245 0 0 _aAnti-progesterones: background and clinical physiology.
_h[electronic resource]
260 _bBailliere's clinical obstetrics and gynaecology
_cSep 1988
300 _a597-607 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAbortifacient Agents
_xtherapeutic use
650 0 4 _aAbortifacient Agents, Steroidal
_xpharmacokinetics
650 0 4 _aAnimals
650 0 4 _aEstrenes
_xpharmacokinetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMacaca fascicularis
650 0 4 _aMifepristone
650 0 4 _aReceptors, Progesterone
_xbiosynthesis
700 1 _aHealy, D L
773 0 _tBailliere's clinical obstetrics and gynaecology
_gvol. 2
_gno. 3
_gp. 597-607
856 4 0 _uhttps://doi.org/10.1016/s0950-3552(88)80046-4
_zAvailable from publisher's website
999 _c3075074
_d3075074